Order Confirmation
One time E-mandate is required for buy orders which is valid for 7 days
PharmEasy is a consumer healthcare Company that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceutical, other consumer healthcare products, comprehensive diagnostic test services, and teleconsultants.
| Buy Price | Orders | Qty |
|---|---|---|
| No Active Buyer | ||
| Sell Price | Orders | Qty |
|---|---|---|
| No Active Seller | ||
| Market Capitalization | N/A | Price High-Low | 13.75 - 8.25 |
| Stock P/E | N/A | 3 Yr CAGR Revenue | |
| EPS | N/A | ROCE | N/A |
| Particular | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| No Record Active | ||||||
| Particular | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| No Record Active | ||||||
| Particular | 2021
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flow from Operating activities
|
-813.68 | ||||||||||||
|
|||||||||||||
|
Cash Flow From Investing activities
|
0.00 | ||||||||||||
|
|||||||||||||
|
Cash Flow From Financing activities
|
0.00 | ||||||||||||
|
|||||||||||||
| Net Increase/Decrease in Cash and Cash Equivalents | 0.00 | ||||||||||||
| Opening Balance of cash & Cash Equivalent | 0.00 | ||||||||||||
| Closing Cash & Cash Equivalents | 0.00 | ||||||||||||
| Free Cash Flow | 0.00 | ||||||||||||
| Date | Investors | No. of Investors | Amount | Series |
|---|---|---|---|---|
| 01 November 2021 | VestinWolf Capital Management | 1 | - 0.00 - | Private Equity Round |
| 20 October 2021 | Trifecta Capital Advisors | 1 | - 0.00 - | Debt Financing |
| 18 October 2021 | IIFL Finance | 1 | - 146.00 - | Secondary Market |
| 18 October 2021 | 8 | - 204.00 - | Venture Round | |
| 07 July 2021 | Arokiaswamy Velumani | 8 | - 500.00 - | Series F |
| 17 June 2021 | B Capital Group | 1 | - 20.00 - | Secondary Market |
| 07 April 2021 | Prosus Ventures, TPG Growth | 18 | - 390.00 - | Series E |
| 07 April 2021 | Prosus Ventures, TPG Growth | 18 | - 390.00 - | Series E |
| 27 November 2019 | Temasek Holdings | 8 | - 220.00 - | Series D |
| 26 September 2018 | Eight Roads Ventures India | 7 | - 50.00 - | Series C |
| 11 September 2018 | InnoVen Capital | 1 | - 400.00 - | Debt Financing |
| Name | Industry | Announced Date | Amount |
|---|---|---|---|
| Aknamed | - | 14 September 2021 | 144.00 |
| Thyrocare Technologies | - | 26 June 2021 | 45.50 |
| Medlife | - | 18 August 2020 | 235.00 |
| Name | Announced Date | Amount | |
|---|---|---|---|
| No Record Active | |||
| Name | Organization |
|---|---|
| Akna Medical Private Limited | https://www.aknamed.com/ |
| Medlife Wellness Retail Private Limited | www.medlife.com |
| Thyrocare Technologies Limited | https://www.thyrocare.com/ |
| Action | Date |
|---|---|
| No Record Active | |
| Company | Status |
|---|---|
| STUDDS ACCESSORIES LIMITED | Listed |
Back to Marketplace
